A next-generation episignature for Kabuki syndrome enables fine mapping of the impact of KMT2D variants to inform precision medicine

Journal:

American Journal of Human Genetics

Published:

2026-05-13

DOI:

10.1016/j.ajhg.2026.04.010

Affiliations:

23

Authors:

27

Go to article

Institutions	Authors	Share
The Hospital for Sick Children (SickKids), U of T, Canada	9.166667	0.34
NYU Langone Health, United States of America (USA)	3.000000	0.11
Radboud University Medical Centre (Radboudumc), RU, Netherlands	1.500000	0.06
Erasmus University Medical Center (Erasmus MC), Netherlands	1.500000	0.06
Lakeridge Health, Canada	1.000000	0.04
Vall d'Hebron Research Institute (VHIR), HUVH ICS, Spain	1.000000	0.04
University of Alberta (U of A), Canada	1.000000	0.04
Institute of Genetics and Molecular and Cellular Biology (IGBMC), France	1.000000	0.04
Sanford Health, United States of America (USA)	1.000000	0.04
Biomedical Research Networking Center on Rare Diseases (CIBERER), Spain	1.000000	0.04
Li Ka Shing Faculty of Medicine, HKU, China	1.000000	0.04
Dongsan Medical Center, KMU, South Korea	1.000000	0.04
University of Toronto (U of T), Canada	0.833333	0.03
Johns Hopkins University (JHU), United States of America (USA)	0.750000	0.03
Broad Institute of MIT and Harvard, United States of America (USA)	0.500000	0.02
Boston Children's Hospital (BCH), United States of America (USA)	0.500000	0.02
Kennedy Krieger Institute, United States of America (USA)	0.500000	0.02
Johns Hopkins Medicine (JHM), JHU, United States of America (USA)	0.250000	0.01
University of Iceland, Iceland	0.250000	0.01
Landspitali - The National University Hospital of Iceland, Iceland	0.250000	0.01

Interested in Bioinformatics and Computational Biology?